ROS1 and cancer: Beyond these stipulations, genomic contexts may confer certain groups as rare cancers even within common cancers (e.g. ROS1 fusions in lung cancer or NTRK fusions in colon cancer) or in an atypical demographic context (e.g. male breast cancers).